What You Should Know:
Berkeley SkyDeck, the global hub for entrepreneurship and a leading accelerator, today announced that it has welcomed the first three companies for its new SkyDeck LSEC Bio Track: AsparaGlue, Editpep, and MZR Neurotech.The inaugural track, created in partnership with the UC Berkeley Life Sciences Entrepreneurship Center (LSEC) through LSEC’s new Venture Grant Program, will assist the UC Berkeley faculty-led teams to launch their own biotech and life sciences
Read More
Biotech startups
Merck Digital Sciences Studio Launches to Support Biomedical Startups
What You Should Know:
- Merck, today announced the launch of the Merck Digital Sciences Studio (MDSS) to enable the generation of innovative technologies for drug discovery and development.
- MDSS will support early-stage biomedical startups with direct investment, access to powerful Azure Cloud computing and opportunities to pilot their technologies in collaboration with discovery and clinical scientists at Merck.
MDSS Accelerator Program Focus
The MDSS is a collaboration between
Read More
Biotech Company Nuritas Raises $45M To Scale Its Peptide Discovery Platform
What You Should Know:
- Nuritas, a biotech company that uses proprietary AI to discover plant-based actives (peptides) and make the products we consume healthier and more sustainable raises $45M in Series B funding led by Cleveland Avenue, LLC. The round also included participation from Cultivian Sandbox Ventures, VisVires New Protein, U2’s Bono and The Edge, Salesforce CEO Marc Benioff and Ali Partovi.
- Founded in 2014, Nuritas’ computational approach to discovery uses
Read More
Fresenius Medical Invests Additional $25M in Biotech Platform Humacyte
What You Should Know:
Fresenius Medical Care (FMC) today announced its plans to invest an additional $25 million in clinical-stage biotechnology platform company Humacyte following the extension of its collaboration in June. Fresenius Medical Care acquired a stake in Humacyte in 2018 for $150M as part of a strategic partnership.
Following the merger of Humacyte with a special purpose acquisition company (SPAC), FMC is increasing its position in the newly combined
Read More
Ori Biotech Lands $30M for Cell and Gene Therapy Manufacturing Platform
What You Should Know:
- Biotech startup Ori Biotech raises $30M in Series A
funding to scale its cell and gene therapy (CGT) manufacturing platform.
- Ori Biotech helps pharmaceutical and biotech companies
develop and manufacture cell and gene therapies. Its patented technology aims
to reduce the manufacturing cost of these life-saving treatments by up to 80%,
allowing them to be more widely accessible for patients.
Ori Biotech Ltd (Ori),
a leading innovator in cell and gene therapy
Read More
Biotech Startup uBiome Raises $83M to Expand World’s Largest Human Microbiome Database
uBiome, a microbial genetics company leveraging artificial intelligence to develop wellness products, clinical tests, and therapeutics based on the microbiome, today announced it has raised $83 million in Series C funding. The round was led by OS Fund, with participation from 8VC, Y Combinator, Dentsu Ventures, and additional new and existing investors. Now, uBiome is mining its database (the world's largest human microbiome database) to discover new therapeutic targets, with an initial focus on
Read More
Ferring Acquires Microbiome Platform Rebiotix
Ferring Pharmaceuticals, a research-driven, specialty biopharmaceutical group has acquired Rebiotix Inc., a late-stage clinical microbiome company focused on harnessing the power of the human microbiome to transform the treatment of challenging diseases. This acquisition brings together two innovative healthcare companies that share a common commitment to exploring and understanding the human microbiome to develop new solutions for patients. Rebiotix’s RBX2660 is a non-antibiotic treatment in
Read More
AI-Driven Drug Discovery Startup twoXAR Lands $10M for Computational Platform
twoXAR, Inc., an artificial intelligence (AI)-driven biopharmaceutical company, announced today that it has raised $10 million in Series A financing led by SoftBank Ventures including follow-on participation from seed investor Andreessen Horowitz. The biotech startup plans to use the funding to build the company’s drug pipeline through partnerships and accelerate preclinical development of existing candidates. Traditional drug discovery and development is estimated to take 10-15 years and
Read More
Atomwise Raises $45M for Artificial Intelligence Platform for Drug Discovery
Atomwise, a San Francisco, CA-based company that develops artificial intelligence systems for drug discovery has raised $45 million in Series A funding led by Monsanto Growth Ventures, B Capital Group and Data Collective. Prior investors Y Combinator, Khosla Ventures, and DFJ also participated in this Series A financing, along with new investors Baidu Ventures, Tencent, and Dolby Family Ventures. The oversubscribed round brings Atomwise’s total capital raised to more than $51 million.Founded in
Read More
SkylineDx Inks Partnership With Mayo Clinic to Develop Diagnostic Tests for Melanoma
SkylineDx, a Netherland-based commercial-stage biotech company has inked a joint development agreement with with Mayo Clinic to develop novel diagnostic tests which will improve clinical decision making for melanoma patients. For SkylineDx, the collaboration with the renowned Mayo Clinic is an important milestone as it allows the company to develop new diagnostic tests and extend its product offering for a broader group of patients and clinicians.The knowledge and experience of SkylineDx in the
Read More
